These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 21229158)

  • 1. Editorial: Marine Natural Products themed issue.
    Nat Prod Rep; 2011 Feb; 28(2):181. PubMed ID: 21229158
    [No Abstract]   [Full Text] [Related]  

  • 2. Complex synthesis yields breast-cancer therapy.
    Ledford H
    Nature; 2010 Dec; 468(7324):608-9. PubMed ID: 21124423
    [No Abstract]   [Full Text] [Related]  

  • 3. [Search for new drugs from natural sources. Marine sponges: cornucopia of the marine].
    Hentschel U; Bringmann G
    Pharm Unserer Zeit; 2010; 39(1):62-6. PubMed ID: 20033952
    [No Abstract]   [Full Text] [Related]  

  • 4. Eribulin in 'field practice': an overview of the Italian experience.
    Barni S
    Future Oncol; 2015; 11(15 Suppl):1-2. PubMed ID: 26235257
    [No Abstract]   [Full Text] [Related]  

  • 5. [Advance of several types of important marine antitumor drugs].
    Zhang JY; Fu LW
    Yao Xue Xue Bao; 2008 May; 43(5):435-42. PubMed ID: 18717327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Developing natural product drugs: Supply problems and how they have been overcome.
    Newman DJ
    Pharmacol Ther; 2016 Jun; 162():1-9. PubMed ID: 26706239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyrtioseragamines A and B, new alkaloids from the sponge Hyrtios species.
    Takahashi Y; Iinuma Y; Kubota T; Tsuda M; Sekiguchi M; Mikami Y; Fromont J; Kobayashi J
    Org Lett; 2011 Feb; 13(4):628-31. PubMed ID: 21247076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Marine pharmacology in 1999: antitumor and cytotoxic compounds.
    Mayer AM; Lehmann VK
    Anticancer Res; 2001; 21(4A):2489-500. PubMed ID: 11724312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Marine pharmacology in 2000: antitumor and cytotoxic compounds.
    Mayer AM; Gustafson KR
    Int J Cancer; 2003 Jun; 105(3):291-9. PubMed ID: 12704660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunomodulatory Effects of Halichondrin Isolated from Marine Sponges and Its Synthetic Analogs in Oncological Applications.
    Dissanayake DS; Nagahawatta DP; Lee JS; Jeon YJ
    Mar Drugs; 2024 Sep; 22(9):. PubMed ID: 39330307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Marine spongean cytotoxins.
    Kobayashi M; Kitagawa I
    J Nat Toxins; 1999 Jun; 8(2):249-58. PubMed ID: 10410335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II study of eribulin mesylate, a halichondrin B analog, in patients with metastatic breast cancer previously treated with an anthracycline and a taxane.
    Vahdat LT; Pruitt B; Fabian CJ; Rivera RR; Smith DA; Tan-Chiu E; Wright J; Tan AR; Dacosta NA; Chuang E; Smith J; O'Shaughnessy J; Shuster DE; Meneses NL; Chandrawansa K; Fang F; Cole PE; Ashworth S; Blum JL
    J Clin Oncol; 2009 Jun; 27(18):2954-61. PubMed ID: 19349550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enriching cancer pharmacology with drugs of marine origin.
    Jimenez PC; Wilke DV; Branco PC; Bauermeister A; Rezende-Teixeira P; Gaudêncio SP; Costa-Lotufo LV
    Br J Pharmacol; 2020 Jan; 177(1):3-27. PubMed ID: 31621891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Scientists are searching the seas for cancer drugs.
    O'Hanlon LH
    J Natl Cancer Inst; 2006 May; 98(10):662-3. PubMed ID: 16705115
    [No Abstract]   [Full Text] [Related]  

  • 15. FDA launches "new use initiative".
    Nat Biotechnol; 1997 May; 15(5):399. PubMed ID: 9131604
    [No Abstract]   [Full Text] [Related]  

  • 16. Anticancer agents from marine sponges.
    Ye J; Zhou F; Al-Kareef AM; Wang H
    J Asian Nat Prod Res; 2015; 17(1):64-88. PubMed ID: 25402340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thwarting tumors: Nereus trolls for cancer cures beneath the sea.
    Wolfson W
    Chem Biol; 2007 Nov; 14(11):1199-201. PubMed ID: 18022556
    [No Abstract]   [Full Text] [Related]  

  • 18. Phase II study of the halichondrin B analog eribulin mesylate in patients with locally advanced or metastatic breast cancer previously treated with an anthracycline, a taxane, and capecitabine.
    Cortes J; Vahdat L; Blum JL; Twelves C; Campone M; Roché H; Bachelot T; Awada A; Paridaens R; Goncalves A; Shuster DE; Wanders J; Fang F; Gurnani R; Richmond E; Cole PE; Ashworth S; Allison MA
    J Clin Oncol; 2010 Sep; 28(25):3922-8. PubMed ID: 20679609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Marine natural products and biomedicine.
    Scheuer PJ
    Med Res Rev; 1989; 9(4):535-45. PubMed ID: 2682078
    [No Abstract]   [Full Text] [Related]  

  • 20. Drug development from marine natural products.
    Molinski TF; Dalisay DS; Lievens SL; Saludes JP
    Nat Rev Drug Discov; 2009 Jan; 8(1):69-85. PubMed ID: 19096380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.